echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > HUMAN BRAIN MAPPING: Alzheimer's disease neuropsychiatric symptoms associated with multimodal brain networks

    HUMAN BRAIN MAPPING: Alzheimer's disease neuropsychiatric symptoms associated with multimodal brain networks

    • Last Update: 2022-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Neuropsychiatric symptoms (NPS) are frequently observed in mild cognitive impairment (MCI) and Alzheimer's disease (AD), involving 80% of AD patients


    Concomitant neuropsychiatric symptoms are associated with accelerated progression of Alzheimer's disease (AD)


    Recently, HUMAN BRAIN MAPPING published a research article by Kaicheng Li et al.


    (2) Assess between-group differences in these identified regions;

    (3) Evaluate the predictive ability of identified brain patterns to cognitive changes;

    (4) Identify common and unique multimodal attributes of the four neuropsychiatric sub-syndromes (psychotic, affective symptoms, hyperactivity, apathy)


    On the basis of AD continuum, with NPS total score as reference, a supervised learning strategy was used to guide four-way multimodal neuroimaging fusion (Amyloid, Tau, gray matter volume, brain function)


    Flowchart of NPS-guided multimodal fusion and predictive analysis


    The result is as follows:

    The determined joint components were referred to the total NPS score


    1.


    2.


    Correlations between imaging feature load and cognitive scores in all subjects

    3.


    Determining the combined components using the NPS sub-syndromic score as a reference

    Multimodal brain regions associated with neuropsychiatric symptoms (NPS) and their predictiveness in cognitive progression


    In conclusion, NPS is associated with multimodal imaging patterns involving complex neuropathology and can effectively predict longitudinal cognitive decline


     

    Original source:

    Neuropsychiatric symptoms associated multimodal brain networks in Alzheimer's disease

    https://onlinelibrary.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.